Overview
These assays are for the detection of specific nodal and paranodal autoantibodies to assist in the diagnosis of autoimmune nodopathy and differentiate from chronic inflammatory demyelinating polyneuropathy.
| Test code: | AN CBA Panel |
| Abbreviations, alternative names: | CIDP Panel, CIDP CBA, NF CBA |
| Methodology: | In-house fixed cell-based assay |
| Validation: | Research use only (RUO) |
Requirements
| Specimen type: | Serum |
| Minimum volume: | 0.5 mL |
| Preferred volume: | 3 mL |
| Rejection criteria: | Grossly hemolytic, lipemic, or icteric. If the sample arrives at room temperature. |
Our offices are only able to receive samples Mon-Fri, so samples must be shipped Mon-Thur. Samples arriving over the weekend may need to be re-drawn.
Specimen
| Specimen collection: | No patient preparation is required for sample collection. |
| Specimen handling: | Centrifuge SST tubes at 1800 - 2200 x g for 10-15 minutes |
| Specimen stability: | Serum samples may be stored: |
Performance
| Testing frequency: | Once every 2 weeks |
| Turnaround time: | 2-3 weeks |
| Reference range: | N/A |
Additional Information
- This test was developed and its performance characteristics determined by BCNI. The test was performed in a DAP, CAP and CLIA certified laboratory and is intended for clinical purposes
- Please indicate if patients are on immunomodulating treatments as these may interfere with testing.
Order Autoimmune Nodopathy / Chronic Inflammatory Demyelinating Polyneuropathy Antibody Panel Test
Reach out to our specialists today to start the ordering process.
Order Test